Cigna Corporation (CI) Shares Bought by Toronto Dominion Bank
Toronto Dominion Bank grew its holdings in shares of Cigna Corporation (NYSE:CI) by 10.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 95,683 shares of the health services provider’s stock after acquiring an additional 8,943 shares during the quarter. Toronto Dominion Bank’s holdings in Cigna Corporation were worth $17,885,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Capstone Investment Advisors Netherlands B.V. acquired a new position in Cigna Corporation during the second quarter worth about $106,000. Saratoga Research & Investment Management acquired a new position in Cigna Corporation during the third quarter worth about $112,000. Parallel Advisors LLC raised its stake in Cigna Corporation by 62.3% during the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock worth $139,000 after acquiring an additional 307 shares in the last quarter. Acrospire Investment Management LLC increased its stake in shares of Cigna Corporation by 66.7% in the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock valued at $167,000 after buying an additional 400 shares during the period. Finally, Financial Architects Inc increased its stake in shares of Cigna Corporation by 186.0% in the second quarter. Financial Architects Inc now owns 1,121 shares of the health services provider’s stock valued at $188,000 after buying an additional 729 shares during the period. 89.69% of the stock is owned by hedge funds and other institutional investors.
WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/11/13/cigna-corporation-ci-shares-bought-by-toronto-dominion-bank.html.
Several research firms have recently issued reports on CI. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $182.00 price objective on shares of Cigna Corporation in a research note on Monday, July 24th. BidaskClub raised Cigna Corporation from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 18th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $191.00 price objective on shares of Cigna Corporation in a research note on Sunday, September 17th. Citigroup Inc. upped their price objective on Cigna Corporation from $185.00 to $198.00 and gave the company a “buy” rating in a research note on Monday, August 7th. Finally, Morgan Stanley upped their price objective on Cigna Corporation from $184.00 to $188.00 and gave the company an “overweight” rating in a research note on Monday, August 7th. Three research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $201.50.
Shares of Cigna Corporation (CI) traded up $0.46 during mid-day trading on Monday, reaching $197.98. The company had a trading volume of 991,000 shares, compared to its average volume of 1,362,323. Cigna Corporation has a 1-year low of $131.03 and a 1-year high of $206.45. The company has a market capitalization of $48,760.00, a PE ratio of 19.07, a PEG ratio of 1.51 and a beta of 0.49. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39.
Cigna Corporation (NYSE:CI) last announced its earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.36 by $0.47. The business had revenue of $10.38 billion for the quarter, compared to analysts’ expectations of $10.17 billion. Cigna Corporation had a return on equity of 18.85% and a net margin of 5.74%. The firm’s revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.94 earnings per share. sell-side analysts predict that Cigna Corporation will post 10.34 earnings per share for the current year.
In other Cigna Corporation news, EVP Lisa R. Bacus sold 2,236 shares of the stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $179.95, for a total transaction of $402,368.20. Following the transaction, the executive vice president now directly owns 18,501 shares in the company, valued at approximately $3,329,254.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director William D. Zollars sold 1,232 shares of the stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total value of $230,667.36. The disclosure for this sale can be found here. Insiders have sold a total of 3,715 shares of company stock worth $678,797 over the last 90 days. Company insiders own 1.30% of the company’s stock.
Cigna Corporation Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).
Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.